Feature | August 13, 2012

Support Services Critical as Providers Migrate to Hybrid OR, Says Recent KLAS Study

August 13, 2012 — Providers are increasingly focused on using interventional labs in a hybrid operating room (OR) environment, but better support and training are needed to ensure success in this evolution of technology, suggests some of the findings in a recent KLAS study, “Interventional X-ray 2012: A Continuing Evolution.”

The research indicates that providers are specifically looking for vendors' training quality and readiness for hybrid OR suites when selecting interventional X-ray systems. Healthcare providers across the United States expressed their opinions regarding four specific vendors in the market. For the third year in a row, Toshiba earned the top score for overall satisfaction, followed by Phillips, GE and Siemens. Providers highlighted Toshiba's field support, proactive service and account management. However, Toshiba has only two of their participating customers currently using the Infinix-i as a hybrid OR.

Conversely, with 13 customers using their equipment in a hybrid OR, Siemens has the greatest market penetration in this area. Although providers rated Siemens fourth place overall, Kirk Ising, report author and strategic operations director at KLAS, says that may come with the territory. The reason is that hybrid OR requires a much more complex process to set up, and training is difficult to coordinate and execute effectively.

"Currently, providers who are using a hybrid OR are early adopters," Ising said. "And although Siemens has been first to the table with the technology piece, they will need to improve their contracting, training and implementation processes to better meet providers' expectations."

While Phillips scored higher than Siemens overall, they only have two customers using the FD20 in a hybrid OR. When it comes to implementations, Philips customers report that communication is excellent. However, communication seems to fall off post-implementation, which appears to disappoint hands-on managers.

Provider satisfaction with GE's Innova 3100 has steadily improved in the past five years, giving GE third place in this study. Better service and support have helped GE make their customers more satisfied. The Innova 3100 is not being used in any hybrid OR settings because it is a floor-mounted unit. In order to tap the hybrid OR market, GE released the Discovery IGS 730, which is meant for hybrid OR use, but there are not enough live sites to measure it for the 2012 study.

For more information: www.KLASresearch.com

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init